Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adriano Chio

Showing results (21-30 of 77) with videos related to

Pageof 8
Sort By:
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|June 3, 2024
Serum heat shock protein concentrations are not associated with amyotrophic lateral sclerosis risk or survival in three European populationsJames P K Rooney, Grainne Geoghegan, Fiona O'Reilly, et al.
BMJ Open|March 27, 2020
G-CSF (filgrastim) treatment for amyotrophic lateral sclerosis: protocol for a phase II randomised, double-blind, placebo-controlled, parallel group, multicentre clinical study (STEMALS-II trial)Paolina Salamone, Giuseppe Fuda, Federico Casale, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|August 23, 2019
Effect modification of the association between total cigarette smoking and ALS risk by intensity, duration and time-since-quitting: Euro-MOTORSusan Peters, Anne E Visser, Fabrizio D'Ovidio, et al.
Brain : a Journal of Neurology|January 12, 2022
The importance of offering early genetic testing in everyone with amyotrophic lateral sclerosisKristiana Salmon, Matthew C Kiernan, Seung H Kim, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|June 5, 2024
Disentangling the relationship between social cognition, executive functions and behaviour changes in amyotrophic lateral sclerosisFrancesca Palumbo, Barbara Iazzolino, Stefano Callegaro, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|July 11, 2022
Respiratory support in a population-based ALS cohort: demographic, timing and survival determinantsAdriano Chio, Cristina Moglia, Antonio Canosa, et al.
Free Radical Biology & Medicine|August 17, 2017
NADPH oxidases as drug targets and biomarkers in neurodegenerative diseases: What is the evidence?Silvia Sorce, Roland Stocker, Tamara Seredenina, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|July 2, 2020
The role of arterial blood gas analysis (ABG) in amyotrophic lateral sclerosis respiratory monitoringUmberto Manera, Maria Claudia Torrieri, Cristina Moglia, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|April 15, 2016
A mapping review of international guidance on the management and care of amyotrophic lateral sclerosis (ALS)Astrid I W A Janssens, Marijke Ruytings, Ammar Al-Chalabi, et al.
European Journal of Neurology|September 15, 2011
EFNS guidelines on the clinical management of amyotrophic lateral sclerosis (MALS)--revised report of an EFNS task force, Peter M Andersen, Sharon Abrahams, et al.
Pageof 8

Showing results (21-30 of 77) with videos related to

Sort By:
Pageof 8
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|June 3, 2024
Serum heat shock protein concentrations are not associated with amyotrophic lateral sclerosis risk or survival in three European populationsJames P K Rooney, Grainne Geoghegan, Fiona O'Reilly, et al.
BMJ Open|March 27, 2020
G-CSF (filgrastim) treatment for amyotrophic lateral sclerosis: protocol for a phase II randomised, double-blind, placebo-controlled, parallel group, multicentre clinical study (STEMALS-II trial)Paolina Salamone, Giuseppe Fuda, Federico Casale, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|August 23, 2019
Effect modification of the association between total cigarette smoking and ALS risk by intensity, duration and time-since-quitting: Euro-MOTORSusan Peters, Anne E Visser, Fabrizio D'Ovidio, et al.
Brain : a Journal of Neurology|January 12, 2022
The importance of offering early genetic testing in everyone with amyotrophic lateral sclerosisKristiana Salmon, Matthew C Kiernan, Seung H Kim, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|June 5, 2024
Disentangling the relationship between social cognition, executive functions and behaviour changes in amyotrophic lateral sclerosisFrancesca Palumbo, Barbara Iazzolino, Stefano Callegaro, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|July 11, 2022
Respiratory support in a population-based ALS cohort: demographic, timing and survival determinantsAdriano Chio, Cristina Moglia, Antonio Canosa, et al.
Free Radical Biology & Medicine|August 17, 2017
NADPH oxidases as drug targets and biomarkers in neurodegenerative diseases: What is the evidence?Silvia Sorce, Roland Stocker, Tamara Seredenina, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|July 2, 2020
The role of arterial blood gas analysis (ABG) in amyotrophic lateral sclerosis respiratory monitoringUmberto Manera, Maria Claudia Torrieri, Cristina Moglia, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|April 15, 2016
A mapping review of international guidance on the management and care of amyotrophic lateral sclerosis (ALS)Astrid I W A Janssens, Marijke Ruytings, Ammar Al-Chalabi, et al.
European Journal of Neurology|September 15, 2011
EFNS guidelines on the clinical management of amyotrophic lateral sclerosis (MALS)--revised report of an EFNS task force, Peter M Andersen, Sharon Abrahams, et al.
Pageof 8